Uses CuratAI's mask-based defacing to process imaging data on the Mayo Clinic Platform — identity removed, intracranial anatomy preserved.
Carina AI · clinical-research software for academic medical centers
Meet CuratAI — the AI-Native Multimodal Data Curation Platform
On-premise data curation for clinical research. Pulls from PACS and EHR, removes PHI, hands back structured cohorts that stay inside the institution.
Before Original
After CuratAI defaced
Drag to compare
- 10+ Academic medical centers
Mayo · JHU · Penn · UVA · Duke · Emory · Colorado · Brown · UTSW · Kentucky - 2 FDA 510(k)-cleared products
INTContour and INTDose · shipping since 2022 - 40+ Peer-reviewed publications
Reviewed by the same people who use the software
How it works
What CuratAI does, end to end
Multi-site clinical research lives or dies on data that's safe to share — de-identified at the pixel and traceable end to end. Carina AI builds CuratAI, the on-premise platform for that work, plus the FDA-cleared clinical AI products built on top of it.
What customers build
Real outcomes on the same stack
Mayo Clinic Arizona · Radiation Oncology
Retrained INTContour on local prostate protocols (iodinated spacers, rectal balloons). Blinded review by 6 GU radiation oncologists and 2 RO residents found AI contours ≥ manual in ≥50% of cases across every structure.
Read the full case study → · Duan et al., Medical Physics, 2023
University of Colorado · Anschutz
Uses CuratAI to build foundation models and accelerate multi-modal data retrieval and processing across the institutional research pipeline.
University of Pennsylvania
Benchmarked four defacing algorithms against CuratAI's. CuratAI delivered the best privacy–utility trade-off — preserving organ volumes with no measurable changes across all structures, while still suppressing facial re-identification.
Read the full case study → · Wang et al., Red Journal, 2026
Beyond CuratAI
The full Carina AI suite
Clinical AI products built on the same on-premise stack — two FDA-cleared, two NIH-supported in active research.
FDA 510(k) K212274 · cleared 2022
INTContour
AI-Native Auto-Contouring Platform
AI auto-contouring for radiation oncology — 120+ OARs across CT, MRI, and PET/CT with automatic quality assurance.
FDA 510(k) K213137 · cleared 2022
INTDose
Independent Dose Verification Platform
Monte Carlo 3-D secondary dose verification. Machine-specific compatibility, customizable DVH and gamma analysis.
NIH-supported · multi-modality
OncoAI Suite
AI-Native Oncology Imaging Suite
Detection, segmentation, measurement, and longitudinal tracking on CT, MRI, and PET/CT — LymphNode, BrainTumor, LungNodule.
CT and MRI · Evans Index
QuantBrain
AI-Native Brain Quantification Platform
Automatic ventricle segmentation and quantitative volumetric measurement for hydrocephalus on CT and MRI.
From research data to clinical reality
One on-premise stack — from the first de-identified cohort to the FDA-cleared product.